177 related articles for article (PubMed ID: 38062659)
21. Spray drying ternary amorphous solid dispersions of ibuprofen - An investigation into critical formulation and processing parameters.
Ziaee A; Albadarin AB; Padrela L; Faucher A; O'Reilly E; Walker G
Eur J Pharm Biopharm; 2017 Nov; 120():43-51. PubMed ID: 28822874
[TBL] [Abstract][Full Text] [Related]
22. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
Indulkar AS; Lou X; Zhang GGZ; Taylor LS
Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846
[TBL] [Abstract][Full Text] [Related]
23. Amorphous solid dispersions: Stability mechanism, design strategy and key production technique of hot melt extrusion.
Han J; Tang M; Yang Y; Sun W; Yue Z; Zhang Y; Zhu Y; Liu X; Wang J
Int J Pharm; 2023 Nov; 646():123490. PubMed ID: 37805146
[TBL] [Abstract][Full Text] [Related]
24. Prediction and Construction of Drug-Polymer Binary System Thermodynamic Phase Diagram in Amorphous Solid Dispersions (ASDs).
Hu Z; Xu P; Ashour EA; Repka MA
AAPS PharmSciTech; 2022 Jun; 23(6):169. PubMed ID: 35715519
[TBL] [Abstract][Full Text] [Related]
25. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
[TBL] [Abstract][Full Text] [Related]
26. Review of industrially recognized polymers and manufacturing processes for amorphous solid dispersion based formulations.
Saha SK; Joshi A; Singh R; Dubey K
Pharm Dev Technol; 2023 Sep; 28(7):678-696. PubMed ID: 37427544
[TBL] [Abstract][Full Text] [Related]
27. Dicarboxylic acid as a linker to improve the content of amorphous drug in drug-in-polymer film: Effects of molecular mobility, electrical conductivity and intermolecular interactions.
Quan P; Wan X; Tian Q; Liu C; Fang L
J Control Release; 2020 Jan; 317():142-153. PubMed ID: 31785302
[TBL] [Abstract][Full Text] [Related]
28. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
[TBL] [Abstract][Full Text] [Related]
29. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.
Baghel S; Cathcart H; O'Reilly NJ
Mol Pharm; 2018 Sep; 15(9):3796-3812. PubMed ID: 30020788
[TBL] [Abstract][Full Text] [Related]
30. Solvent influence on the phase behavior and glass transition of Amorphous Solid Dispersions.
Dohrn S; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
Eur J Pharm Biopharm; 2021 Jan; 158():132-142. PubMed ID: 33212185
[TBL] [Abstract][Full Text] [Related]
31. Molecular Simulation and Statistical Learning Methods toward Predicting Drug-Polymer Amorphous Solid Dispersion Miscibility, Stability, and Formulation Design.
Walden DM; Bundey Y; Jagarapu A; Antontsev V; Chakravarty K; Varshney J
Molecules; 2021 Jan; 26(1):. PubMed ID: 33401494
[TBL] [Abstract][Full Text] [Related]
32. Investigation into Intermolecular Interactions and Phase Behavior of Binary and Ternary Amorphous Solid Dispersions of Ketoconazole.
Sarpal K; Tower CW; Munson EJ
Mol Pharm; 2020 Mar; 17(3):787-801. PubMed ID: 31860316
[TBL] [Abstract][Full Text] [Related]
33. Drug-polymer-water interaction and its implication for the dissolution performance of amorphous solid dispersions.
Chen Y; Liu C; Chen Z; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
Mol Pharm; 2015 Feb; 12(2):576-89. PubMed ID: 25535667
[TBL] [Abstract][Full Text] [Related]
34. Corroborating various material-sparing techniques with hot melt extrusion for the preparation of triclabendazole amorphous solid dispersions.
Palekar S; Mamidi HK; Guo Y; Vartak R; Patel K
Int J Pharm; 2023 Jun; 640():122989. PubMed ID: 37120123
[TBL] [Abstract][Full Text] [Related]
35. Amorphous Solid Dispersions: Utilization and Challenges in Drug Discovery and Development.
He Y; Ho C
J Pharm Sci; 2015 Oct; 104(10):3237-58. PubMed ID: 26175316
[TBL] [Abstract][Full Text] [Related]
36. Molecular-Level Examination of Amorphous Solid Dispersion Dissolution.
Faiz Afzal MA; Lehmkemper K; Sobich E; Hughes TF; Giesen DJ; Zhang T; Krauter CM; Winget P; Degenhardt M; Kyeremateng SO; Browning AR; Shelley JC
Mol Pharm; 2021 Nov; 18(11):3999-4014. PubMed ID: 34570503
[TBL] [Abstract][Full Text] [Related]
37. Strategies to improve the stability of amorphous solid dispersions in view of the hot melt extrusion (HME) method.
Al-Japairai K; Hamed Almurisi S; Mahmood S; Madheswaran T; Chatterjee B; Sri P; Azra Binti Ahmad Mazlan N; Al Hagbani T; Alheibshy F
Int J Pharm; 2023 Nov; 647():123536. PubMed ID: 37865133
[TBL] [Abstract][Full Text] [Related]
38. Inhomogeneous Phase Significantly Reduces Oral Bioavailability of Felodipine/PVPVA Amorphous Solid Dispersion.
Gao D; Zhu D; Zhou X; Dong S; Chen Y
Mol Pharm; 2023 Jan; 20(1):409-418. PubMed ID: 36529939
[TBL] [Abstract][Full Text] [Related]
39. A Comparison of Spray-Drying and Co-Precipitation for the Generation of Amorphous Solid Dispersions (ASDs) of Hydrochlorothiazide and Simvastatin.
Myślińska M; Stocker MW; Ferguson S; Healy AM
J Pharm Sci; 2023 Aug; 112(8):2097-2114. PubMed ID: 36805392
[TBL] [Abstract][Full Text] [Related]
40. Analytical and Computational Methods for the Determination of Drug-Polymer Solubility and Miscibility.
Thakore SD; Akhtar J; Jain R; Paudel A; Bansal AK
Mol Pharm; 2021 Aug; 18(8):2835-2866. PubMed ID: 34041914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
